Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $6.10 $80.02 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
May 10, 2016 $28.00 $28.00 $28.00 $28.00 75 620
May 09, 2016 $24.96 $24.96 $24.96 $24.96 85 479
May 06, 2016 $24.16 $24.16 $24.16 $24.16 88 122
May 05, 2016 $24.96 $24.96 $24.96 $24.96 72 567
May 04, 2016 $25.76 $25.76 $25.76 $25.76 81 853
May 03, 2016 $28.48 $28.48 $28.48 $28.48 44 787
May 02, 2016 $28.56 $28.56 $28.56 $28.56 54 082
Apr 29, 2016 $29.60 $29.60 $29.60 $29.60 62 897
Apr 28, 2016 $30.40 $30.40 $30.40 $30.40 49 692
Apr 27, 2016 $30.40 $30.40 $30.40 $30.40 37 939
Apr 26, 2016 $31.76 $31.76 $31.76 $31.76 48 091
Apr 25, 2016 $33.28 $33.28 $33.28 $33.28 39 677
Apr 22, 2016 $34.16 $34.16 $34.16 $34.16 49 818
Apr 21, 2016 $34.48 $34.48 $34.48 $34.48 108 766
Apr 20, 2016 $30.88 $30.88 $30.88 $30.88 50 061
Apr 19, 2016 $30.16 $30.16 $30.16 $30.16 58 869
Apr 18, 2016 $31.76 $31.76 $31.76 $31.76 52 506
Apr 15, 2016 $30.80 $30.80 $30.80 $30.80 34 481
Apr 14, 2016 $30.64 $30.64 $30.64 $30.64 62 573
Apr 13, 2016 $29.76 $29.76 $29.76 $29.76 61 282
Apr 12, 2016 $28.08 $28.08 $28.08 $28.08 58 456
Apr 11, 2016 $27.92 $27.92 $27.92 $27.92 119 069
Apr 08, 2016 $30.72 $30.72 $30.72 $30.72 100 845
Apr 07, 2016 $32.48 $32.48 $32.48 $32.48 134 607
Apr 06, 2016 $33.12 $33.12 $33.12 $33.12 97 151
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT